Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Hemoblock_S (Prescription); Hemoblock_S (OTC)

K-Number: K232216 · 2024-04-19

Decision Date2024-04-19
Product CodeQSY
DecisionSubstantially Equivalent

Device Summary

Hemoblock_S (Prescription); Hemoblock_S (OTC) is a medical device manufactured by Incore Co., Ltd.. It received FDA 510(k) clearance on 2024-04-19 under approval number K232216. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Hemoblock_S (Prescription); Hemoblock_S (OTC)?

Hemoblock_S (Prescription); Hemoblock_S (OTC) is a medical device that received FDA 510(k) clearance on 2024-04-19. It is manufactured by Incore Co., Ltd.. The 510(k) number is K232216.

When was Hemoblock_S (Prescription); Hemoblock_S (OTC) approved by the FDA?

Hemoblock_S (Prescription); Hemoblock_S (OTC) received FDA 510(k) clearance on 2024-04-19, under approval number K232216.

What company makes Hemoblock_S (Prescription); Hemoblock_S (OTC)?

Hemoblock_S (Prescription); Hemoblock_S (OTC) is manufactured by Incore Co., Ltd..

What is the FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC)?

The FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC) is QSY.

Other Devices by Incore Co., Ltd.

Related Devices (Code: QSY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.